PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-5.88%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.32%
Less D&A growth vs. META's 11.33%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
169.23%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
6.19%
Less SBC growth vs. META's 16.57%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1420.00%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-628.26%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
156.06%
Inventory growth of 156.06% while META is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-34.17%
Negative yoy AP while META is 144.49%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-234.69%
Negative yoy usage while META is 93.48%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-90.00%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-19.31%
Negative yoy CFO while META is 6.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-99.16%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-20.53%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-5.37%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
17.27%
Below 50% of META's 198.35%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
104.06%
We have mild expansions while META is negative at -29.73%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-625.77%
We cut yoy buybacks while META is 20.28%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.